Fig. 2: Incremental cost-utility results (ICUR) estimates of included studies. | npj Digital Medicine

Fig. 2: Incremental cost-utility results (ICUR) estimates of included studies.

From: Cost effectiveness review of text messaging, smartphone application, and website interventions targeting T2DM or hypertension

Fig. 2

Note that McManus et al.28 did not calculate an ICUR as QALY difference was insignificant. ICUR estimates in Cunningham et al.29 and Wong et al.34 were dominant. CG control group. *: asterisk denotes studies targeting populations with hypertension; studies without an asterisk include people with (pre)diabetes.

Back to article page